ライフサイエンスコーパス: advocacy

1 illustrating the impact of ID/HIV physician advocacy.

2 eillance, healthcare delivery, and effective advocacy.

3 ical oncology, guideline implementation, and advocacy.

4 ned with adaptations in programme design and advocacy.

5 crobiology, laboratory medicine, and patient advocacy.

6 strengthened by training and community-based advocacy.

7 l resource for those involved in legislative advocacy.

8 ence, public and professional education, and advocacy.

9 ion, the community, and at work, and through advocacy.

10 ional research, health economics and patient advocacy.

11 o link neuroscience education, research, and advocacy.

12 populations through research, education, and advocacy.

13 ient safety research, regulation, or patient advocacy.

14 patient/clinician, confessions, and patient advocacy.

15 cal commitment via global communications and advocacy; (2) informing national decision-making, planni

16 nings and meetings, 8% to communications and advocacy, 9% to logistics, 15% to monitoring, and 5% to

17 n work of the IMG; high-level engagement and advocacy across partners; the strong foundations of the

18 tion strategies and global collaboration and advocacy, aimed at improving the uptake, cost-effectiven

19 From the outset of the project, advocacy and communication strategies were developed and

20 n Consortium to "Take on Typhoid," combining advocacy and communications efforts to mobilize research

21 g logisticians and health workers, fostering advocacy and communications, establishing monitoring and

22 rticle, we present a brief history of cancer advocacy and discuss the variety of ways advocates have

23 Efforts in advocacy and education are necessary to ensure that effe

24 servation for devastating consequences, self-advocacy and education, needing lifestyle advice, tracki

25 evaluate our project, "Linking Breast Cancer Advocacy and Environmental Justice," to help identify su

26 l require renewed effort and focus on vision advocacy and expanding eye care services worldwide.

27 ing the nature of these injuries can lead to advocacy and hopefully legislation to prevent further in

28 urther expanded the community of science and advocacy and increased the understanding of the disease

29 d feels loved (n=68), child's health (n=56), advocacy and informed (n=55), and spiritual well-being (

30 is largely reflects the conceptualization of advocacy and its purpose.

31 d for successful treatment and is a powerful advocacy and monitoring tool.

32 ds between and within states, and supporting advocacy and policy development by state and local gover

33 happening in Africa, driven by international advocacy and policy directives and supported by unpreced

34 Over 2 decades of VISION 2020 advocacy and program implementation have culminated in a

35 he article also describes best practices for advocacy and provides case studies illustrating the impa

36 In 2006, following direct advocacy and published rationale, the US Agency for Inte

37 Strong advocacy and resources are needed to overcome challenges

38 of a novel program designed to promote both advocacy and systems training among transplant candidate

39 These data suggest that both advocacy and systems training are needed to increase act

40 ctices recorded 223 referrals of patients to advocacy and the 24 control practices recorded 12 referr

41 the domains of clinical care, research, and advocacy and to create an action plan and performance fr

42 is to discuss the exciting field of research advocacy and to help shape a more productive future for

43 h; and accelerate progress through evidence, advocacy, and accountability.

44 andates, institutional policies, grass-roots advocacy, and changing attitudes in the research communi

45 Together with social networking, advocacy, and education, a few specialised centres have

46 use it provides the foundation for research, advocacy, and educational efforts.

47 This evidence suggests that women-centred, advocacy, and home-visitation programmes can reduce a wo

48 multisectoral approach, strong civil society advocacy, and keen political leadership.

49 mbership--mentorship, exemplary role models, advocacy, and leadership.

50 rses to move to higher levels of leadership, advocacy, and policy making (ie, national cancer control

51 change this situation will take commitment, advocacy, and political courage to advance the action ag

52 tments in its research, quality improvement, advocacy, and public health programs.

53 ry action for environmental health research, advocacy, and regulation, we conducted a media analysis

54 ation, behavioral psychology, patient/parent advocacy, and technology.

55 served by current provision of mental health advocacy, and there is a risk that this will be replicat

56 iverse referral and care systems; increasing advocacy; and funding and technical skills to build audi

57 This needs efforts in terms of advocacy, application of legal standards, and public-hea

58 Challenges to effective advocacy are described, and recommendations for increasi

59 ions for both commissioning and provision of advocacy are explored.

60 Improved data and advocacy are needed to increase the availability and app

61 ggests that mainstream conceptualizations of advocacy are not meaningful to these communities and thi

62 Through a case study of advocacy around flame retardant chemicals, this paper tr

63 lved in global ECD leadership, practice, and advocacy, as well as peer-reviewed research, organisatio

64 Increased awareness and advocacy at both the local government and international

65 ed: Managing Competing Knowledge, Vigilance, Advocacy, Balancing Parental Work and the Burdens of Tre

66 stablish a framework for successful research advocacy based on a review of many early initiatives cou

67 adult medicine, pediatrics, nursing, patient advocacy, bioethics, philosophy, and law.

68 ocial work, gerontology, geriatrics, patient advocacy, bioethics, philosophy, elder law, and health l

69 e overcome by cementing our resolve, raising advocacy, bolstering global funder investments, and leve

70 for each population, strengthening of media advocacy, building of citizen protest and engagement, an

71 of expanded treatment options, research, and advocacy built on existing knowledge and science provide

72 ion of their message if they not only eschew advocacy but also, convey that they are sharers of knowl

73 There is an urgent need for advocacy by clinicians and professional societies to res

74 een public- and private-sector research, and advocacy by concerned civil society groups interact to d

75 Advocacy by pediatric healthcare providers to promote in

76 Here I discuss the importance of science advocacy by researchers, and present strategies for comm

77 of a process that began 4 years ago, through advocacy by the Heart Failure Society of America.

78 e degree of sustained and effective domestic advocacy by the local surgical community, the national p

79 explain trends, but legislative activity and advocacy campaigns by nongovernmental organizations may

80 ary response protocols, research, and policy advocacy can enhance the impact of antitrafficking healt

81 The Section has developed work groups in advocacy, clinical practice, education and training, qua

82 sts; support for parents' and young people's advocacy; collaboration between children's research char

83 The Society of Critical Care Medicine Advocacy Committee recognized that there are not enough

84 rom national tuberculosis programmes and the advocacy community provided distinct country-specific in

85 ices research, and clinical oncology and the advocacy community, with a comprehensive review of the d

86 pany, government offices, and scientific and advocacy conferences.

87 peutic window trial designs, and ethical and advocacy considerations are also discussed.

88 Advocacy could help to mobilise needed resources, raise

89 countries have generated evidence to support advocacy, detailed baseline capabilities, and informed t

90 Education and advocacy directed to the referring clinician reinforce t

91 esenting relevant medical, psychosocial, and advocacy disciplines to create a blueprint for the train

92 are paramount to identify priority areas for advocacy, education, and research to improve patient out

93 ge with two doses of measles vaccine through advocacy, education, and the strengthening of routine im

94 wo decades provided a base from which public advocacy, education, fund-raising, and communication hav

95 by gaps in knowledge, diagnosis, treatment, advocacy, education, legislation, and research.

96 However, the advocacy effort must be broad-based and repeatedly prese

97 isk and highlight the need for education and advocacy efforts focused on these at-risk populations.

98 In the meantime, the advocacy efforts of established and emerging PID network

99 cations for psychiatric practice and related advocacy efforts of psychiatrists, psychiatric organizat

100 ital readmission rates, the outcome of their advocacy efforts remains uncertain.

101 des immediate practice improvements and also advocacy efforts surgeons can take to address the threat

102 pitals (PCI capable), as well as coordinated advocacy efforts to work with payers and policy makers t

103 w where to begin or are uncertain that their advocacy efforts will have an impact.

104 are within national health policy, sustained advocacy efforts, effective framing of the problem and s

105 ss of health disparities will likely improve advocacy efforts, public health policy and the quality o

106 advances, including crowdsourcing of patient advocacy efforts, rigorous experimental design of public

107 which has been the focus of recent worldwide advocacy efforts.

108 ngthen global control efforts, research, and advocacy--even more pressing.

109 h a unique blend of political, academic, and advocacy experience.

110 tion oncology, guideline implementation, and advocacy experts and conducted a systematic literature r

111 ogy, surgical oncology, palliative care, and advocacy experts and conducted a systematic review of li

112 logy, gastroenterology, palliative care, and advocacy experts and conducted a systematic review of th

113 tion oncology, guideline implementation, and advocacy experts and conducted a systematic review of th

114 ogy, pulmonary, radiology, primary care, and advocacy experts to conduct a literature search, which i

115 l oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which i

116 l oncology, surgery, radiation oncology, and advocacy experts to conduct a literature search, which i

117 adiation oncology, radiology, pathology, and advocacy experts to conduct a literature search, which i

118 logy, gastroenterology, palliative care, and advocacy experts to conduct a systematic review of the l

119 ommunication skills, health disparities, and advocacy experts to produce recommendations.

120 that combine conversational themes within an advocacy field that are seldom discussed together.

121 -scientists, but also for stimulating public advocacy for biomedical research in this country.

122 scovery often reflects the art, science, and advocacy for biomedical research.

123 Provision of mental health advocacy for black and minority ethnic communities is pa

124 now available worldwide to move forward with advocacy for child and adolescent mental health policy d

125 ions of genetic kidney diseases, responsible advocacy for kidney health and management of conflicts o

126 The advocacy for MSA and necessary capacity building will be

127 Training and advocacy for pathology are also needed.

128 d patient societies involved in the care and advocacy for patients with IEI.

129 egislative developments confirm the right to advocacy for people experiencing mental health problems.

130 t of clinicians in eye-banking practices and advocacy for pursuing meaningful research in this area w

131 urrent context with uncompromising, explicit advocacy for radical transitions in core attitudes and p

132 any of the beneficiaries of NIH support view advocacy for research funding as "someone else's job".

133 foundation on which a companion document on advocacy for rheumatic heart disease has been developed.

134 Research in, implementation of, and advocacy for risk reduction of cardiovascular disease in

135 atment are sometimes ineffectual, leading to advocacy for self-directed preventative measures.

136 ctitioners of ensuring access to appropriate advocacy for service users from black and minority ethni

137 ciated medical issues, and engender directed advocacy for specific genetic conditions.

138 mortality rates, further exploration of and advocacy for the implementation of this process appear w

139 There is now an emerging advocacy for the use of kidneys with existing tumors, wh

140 sensory processing has led to the increased advocacy for the use of opioids for pain relief in infan

141 nfect the same individuals, there is growing advocacy for their concurrent treatment.

142 Parental advocacy for their infant's best interest mimics this va

143 Since then, global advocacy for these conditions has increased and, with it

144 AHA guidelines committee should soften their advocacy for this intervention until conclusive evidence

145 essional lawyers, who are trained to prevent advocacy from biasing their judgements.

146 s should ask and offer tips to help separate advocacy from evidence-based positions.

147 ned and educated to provide pediatric cancer advocacy, fundraising, and (in concert with government)

148 oordinating actions in countries in which no advocacy group exists.

149 esearch Registry, coordinated by the patient advocacy group PC Project, shows that there is considera

150 logy and the International FPIES Association advocacy group.

151 e how to form and maintain a student science advocacy group.

152 of the Chordoma Foundation, a global patient advocacy group.

153 any CeD patients also participate in patient advocacy groups (PAGs) for education and support.

154 a organisation providing support to national advocacy groups and coordinating actions in countries in

155 eveloped by eight representatives of patient advocacy groups and five healthcare professionals and re

156 Representatives of eight patient advocacy groups and five healthcare-research specialists

157 ic evidence and concern is marshaled by both advocacy groups and media sources to affect policy chang

158 hese recommendations can provide guidance to advocacy groups at other research and academic organizat

159 rcycle helmet laws remain controversial, and advocacy groups continue their lobbying efforts to resci

160 More concerted efforts by professional advocacy groups devoted to informing about the benefits

161 ce recognized that recent efforts by patient advocacy groups have played instrumental roles in improv

162 Professional medical organizations and advocacy groups should raise awareness, provide educatio

163 continue to pursue partnerships with cancer advocacy groups to achieve reductions in chronic disease

164 m academia, industry, government and patient advocacy groups to discuss progress, challenges, gaps an

165 ates has sparked the formation of grassroots advocacy groups to empower female scientists in training

166 nal societies, payers, patients, and patient advocacy groups to join in this commitment.

167 International colleagues, work with patient advocacy groups to promote community awareness, and cond

168 This is despite the encouragement of advocacy groups to seek prompt attention for stroke symp

169 Clinicians, scientists, patient advocacy groups, and government agencies worldwide are d

170 borations with junior investigators, patient advocacy groups, and international colleagues.

171 community and academic oncologists, patient advocacy groups, and other stakeholders including the ph

172 sidential proclamation, federal legislation, advocacy groups, and popular media.

173 ong government, philanthropic organizations, advocacy groups, and scientists offers for the first tim

174 onsortium members, outside speakers, patient advocacy groups, and young investigators and trainees to

175 ry relationships and engagement with patient advocacy groups, as well as the National Institutes of H

176 caused by de novo variants can guide patient advocacy groups, clinicians, researchers, and policymake

177 ne has been a major focus of research teams, advocacy groups, funding agencies, and patients and thei

178 seases, working with other organizations and advocacy groups, led the development of the first clinic

179 Input was received from patient advocacy groups, medical oncologists, pharmaceutical com

180 Stakeholder panels, consisting of advocacy groups, patients, researchers, clinicians, fund

181 with representatives from the NHLBI, patient advocacy groups, pharmaceutical companies, and the U.S.

182 Principal investigators, patient advocacy groups, research assistants, and trainees work

183 dings provide a framework for policy makers, advocacy groups, researchers, clinicians, communities, a

184 organizations, federal agencies, and patient advocacy groups, the National Institute of Allergy and I

185 th 15% greater availability; and in terms of advocacy groups, the participation of family-based organ

186 sts, regulators, people living with HIV, and advocacy groups, to discuss the main challenges concerni

187 financing, human resources, and the role of advocacy groups.

188 care providers, community organizations, and advocacy groups.

189 rch funding provided through private, parent advocacy groups.

190 essional disciplines, community members, and advocacy groups.

191 sentatives from national patient and patient advocacy groups.

192 dging France's history could help strengthen advocacy in favour of universal health coverage and cont

193 medicine; clinical practice models; role of advocacy in health care policy and government; personal

194 ent advances grew from clinical research and advocacy in many countries, and global husbandry of such

195 hild's capacity allows, and to place patient advocacy in the informed consent process above productio

196 The majority found the advocacy information surprising, interesting, effectivel

197 erved as the foundation for a broad range of advocacy initiatives and programs that serve as a founda

198 e median (interquartile range) best modified Advocacy-Inquiry Score was significantly better in the i

199 inded to group allocation using the modified Advocacy-Inquiry Score.

200 The interrater reliability of the modified Advocacy-Inquiry Scores (intraclass correlation coeffici

201 are engaging in hypothesis confirmation and advocacy instead of hypothesis testing.

202 many advocates is that the biasing effect of advocacy is controllable.

203 Parent and young people's advocacy is fragmented, and their views are insufficient

204 Here we explain why science advocacy is important and provide steps on how to get in

205 Advocacy is needed to increase funding for tuberculosis

206 Effective advocacy is needed, particularly in the United States, t

207 = 3,104) we show that the biasing effect of advocacy is not controllable but automatic.

208 portant forums for public deliberation about advocacy issues.

209 ation), and cautious donor recruitment (self-advocacy, lacking self-confidence, avoiding donor coerci

210 a temporary ostomy (OR=4.0) or had accessed advocacy-led cancer support were more likely to experien

211 Longer term supported advocacy may be needed.

212 More robust advocacy may ensure a similar regulatory mandate support

213 isparities have resulted in national patient advocacy mobilization, US congressional inquiry, and leg

214 Government advocacy, national guidelines, collaborative research, o

215 This article discusses the advocacy of ID/HIV physicians and other healthcare profe

216 litis has evolved over time, with increasing advocacy of primary anastomosis for acute diverticulitis

217 erences in associations, the results support advocacy of public health and medical actions toward obe

218 tical flaw in Branigan & Pickering's (B&P's) advocacy of structural priming is the absence of a theor

219 will require the sustained collaboration and advocacy of the entire global cancer community.

220 lity to shepherd that change with thoughtful advocacy of their research and careful ethical scrutiny

221 he current situation is very crucial for the advocacy of tobacco control in the age of social media.

222 Advocacy on the basis of this evidence is required to bu

223 anges in reporting requirements of insurers, advocacy on the part of patients, and incorporation of c

224 other contributions to public policy such as advocacy or public testimony, experimentation and scient

225 entists, industry partners, governments, and advocacy organisations.

226 As an evidence-based patient advocacy organization dedicated to improving the cardiov

227 r governmental organizations) and foundation/advocacy organization sites than in personal commentary

228 nd were most often recommended in foundation/advocacy organization websites.

229 PXE International, a patient advocacy organization, supports research in part by spon

230 y trained peer counselors at a breast cancer advocacy organization, the Y-ME National Breast Cancer O

231 coalition of environmental and public health advocacy organizations and an investigative journalism s

232 e Montreal Children's Hospital, food allergy advocacy organizations and organizations providing produ

233 I argue that advocacy organizations are more likely to inspire commen

234 specialty, health care quality, and patient advocacy organizations categorized the 27 identified mea

235 Awareness and referrals to patient advocacy organizations in the CSD among Texas dermatolog

236 ocial scientists have not explained why some advocacy organizations produce social media messages tha

237 Patient advocacy organizations seek to increase their benefits f

238 m sample of business, government, and social advocacy organizations' press releases about climate cha

239 rowing coalition of researchers, clinicians, advocacy organizations, academic institutions, and other

240 held various discussions with expert groups, advocacy organizations, and scientific societies; and he

241 ossible through the collaborative efforts of advocacy organizations, industry, and government with cl

242 At a gathering of agency officials, patient advocacy organizations, industry/professional stakeholde

243 , controlling for various characteristics of advocacy organizations, their social media audiences, an

244 than in sites from scientific and foundation/advocacy organizations.

245 Austria, the network of national EB patient advocacy organizations.

246 determinants, civil society empowerment and advocacy, out-of-health and within-health-sector changes

247 delivered at scale in the context of policy advocacy (PA) in Bangladesh and Viet Nam.

248 scade can be used for routine monitoring and advocacy, particularly by attaching 90-90-90-style targe

249 ons will be dependent on healthcare provider advocacy, patient education, implementation and enforcem

250 With new knowledge and increased parental advocacy, physicians face ethical decisions in formulati

251 cific actions for stillbirths are needed for advocacy, policy formulation, monitoring, and research,

252 es, definitions of ethical norms, and public advocacy positions carry great weight with physicians an

253 e not addressed by oncology, primary care or advocacy professionals.

254 orking on local, national, and international advocacy programs for polio eradication, assisting at im

255 ish local technical capacity and lead health advocacy programs to prevent future disasters.

256 Local, place-based advocacy projects that are strongly grounded within thei

257 Advocacy provided by black community and voluntary secto

258 largely disenfranchised, lacking sufficient advocacy, public attention, and funding.

259 The pillars of the College-advocacy, quality, education, and member engagement-serv

260 established; and methods were developed for advocacy, quantification, demand generation, supply chai

261 t of vesicoureteral reflux is evolving, with advocacy ranging from a less interventional assessment a

262 ral approaches are essential to advance, and advocacy remains a key pillar.

263 nonacademic organizations using the Patient Advocacy Reporting System (PARS).

264 provement Program and the Vanderbilt Patient Advocacy Reporting System from January 1, 2011, to Decem

265 24 months of data in the Vanderbilt Patient Advocacy Reporting System preceding the date of the oper

266 gy, including new advances in clinical care, advocacy, research, and education.

267 lege of Physicians and its members regarding advocacy, research, and practice.

268 ndidates and living donors by separating the advocacy role from the candidate and improving potential

269 Key drivers included the advocacy role of civil society and political leadership

270 ling to advocate for the candidate) for this advocacy role.

271 vored to prevent unmarked deaths by adopting advocacy roles to "fill the gap" of absent family and by

272 The advocacy scenarios illustrated the high impact of detect

273 recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and populat

274 ribution of primary care, community care and advocacy services to cancer survivorship care; these ser

275 ed referral of patients to domestic violence advocacy services.

276 ic violence and their referral to specialist advocacy services.

277 for improved identification and referral to advocacy services.

278 s and perceptions of support from health and advocacy services.

279 These advocacy skills can be used to inform domestic and globa

280 ted efforts of research and professional and advocacy stakeholders, recent evidence suggests that imp

281 erican Heart Association (AHA) public policy advocacy strategies are based on its Strategic Impact Go

282 service delivery, educational campaigns, and advocacy that match the need for their state.

283 xperience of antimicrobial stewardship (AMS) advocacy, the Infectious Diseases Society of America (ID

284 public awareness will provide a platform for advocacy to create national research programs and health

285 academia, government, industry, and patient advocacy to discuss gaps and opportunities in clinical a

286 modeling, pathology, bioethics, and patient advocacy to identify factors to consider when undertakin

287 Advocacy to improve understanding of mental disorders; i

288 ions and technologies, (4) research, and (5) advocacy to increase global awareness, resources, and ca

289 field of population and development, and an advocacy tool for highlighting the benefits of family pl

290 PFP has utility as an advocacy tool to promote healthy lifestyle behaviours.

291 rs have the power to do so through research, advocacy, training, convening, policymaking, and financi

292 the development of independent mental health advocacy, under the amendments to the UK Mental Health A

293 Social mobilization and political advocacy, used in tandem with technical solutions, is an

294 tten center policies and confusion regarding advocacy versus stewardship roles were consistently iden

295 ore scientists to become involved in science advocacy, we describe how to form and maintain a student

296 Public health partnerships and advocacy will be crucial to remove barriers to enhanced

297 HIV prevention methods, social and political advocacy will be needed to overcome these barriers and i

298 e is a dearth of literature on mental health advocacy with black and minority ethnic communities.

299 up, care managers provided communication and advocacy with medical providers, health education, and s

300 efforts in planning, policy, leadership and advocacy, workforce training and development, and monito